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Abstract - With the emergence and rapid advancement o f DNA
microarray technologies, construction of gene expression
profiles for different cancer types has already become a
promising means for cancer diagnosis and treatment. Mosl
previous research has focused on binary classification. Here, we
use a probabilistic neural nehvork (PNN) for multi-classification
of cancer data.
The experimental results demonstrate the
effectiveness of the PNN in addressing gene expression data.

I INTRODUCTION
With the emergence and rapid advancement of DNA
microarray technologies [ 1-21, cancer classification through
identifying the corresponding gene expression profiles has
already attracted numerous efforts from a wide variety of
research communities [3-161. Cancer classification is
important to the subsequent diagnosis and treatment. Without
the correct identification of cancer types, it is rarely possible
to provide useful therapies and achieve expecting effects.
Traditional classification methods are largely dependent on
morphological appearance of tumors, and their applications
are limited by the existing uncertainties [3]. Tumors with
similar appearance may have quite different origins and
therefore respond differently for the same treatment therapy.
For example, in diffuse large B-cell lymphoma (DLBCL),
almost half of clinical cases fail to the treatment due to the
existence of unknown subtypes that cannot be discriminated
by their morphologic parameters [4]. DNA microarray
technologies offer caner researchers a new way to investigate
the pathologies of cancer from the molecular angle, and
further, to make more accurate predictions in prognosis and
treatment.
There exist different types of microarray technologies
based on the nature of the attached DNA (cDNA with length
varying from several hundred to thousand bases or
oligonucleotides containing 20-30 bases). For cDNA
technologies, a microarray consists of a solid substrate to
which a large amount of cDNA clones are attached according
to some certain order [I]. Fluorescently labeled D N A ,
obtained from RNA samples of interest (e.g. tumor samples)
through the process of reverse transcription, is hybridized
with the array. A reference sample (e.g. normal samples) with
a different fluorescent label is also required for the purpose of
comparison. Image analysis techniques are then used to
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measure the fluorescence of each dye after the genes are
washed off. The resulting ratio reflects relative levels of gene
expression. For high-density oligonucleotide microarray,
oligonucleotides are fixed on a chip through techniques like
photolithography and solid-phase DNA synthesis [2]. With a
wealth of gene expression data at hand, researchers have
more opportunities, while inevitably facing new challenges.
Gene expression data sets usually have features like high
dimensionality, high redundancy and inherent noise, which
ask for the computational analysis methods to have
corresponding mechanism to deal with them. Research on
gene expression data is summarized in three levels, according
to the task complexity [17]. The bottom level investigates the
activities of single genes under different conditions or tissues.
The second level focuses on the relations and interactions
among genes and conditions. The top level attempts to infer
the whole genetic network that finally determines all the
pattems we observed. The tumor classification researches
based on gene expression data can be classified into the
intermediate level, which explores the relations between
types of tumors and gene markers.
This kind of research has already been reported in the
literature with promising results [3-161. Golub et al. deemed
cancer classification as two challenges: class discovely and
class prediction and used several strategies: including
weighted voting, neighborhood analysis and self-organizing
feature maps (SOFMs) to discriminate two types of human
acute leukemias (ALL vs. AML) [3]. According to their
results, two subsets of acute lymphoblastic leukemia (ALL),
with different origin of lineage, are also well separated.
Alizadeh et al. distinguished two molecularly distinct
subtypes of diffuse large B-cell lymphoma by their gene
expression profiles [4]. Alon et al. performed a two-way
clustering for both colon tissues and genes and revealed the
potential relations between them [5]. Other explorations
include ovarian cancer [6], breast cancer [7], cutaneous
melanoma [PI, and so on. For most of the researches
aforementioned, hierarchical clustering (HC) is employed.
Although HC has the advantage such as informative
visualization of the clustering results and the versatility, it
lacks robustness and does not have favorable scalability
properties. We have used a new family of neural network
architecture - Ellipsoid ART and ARTMAP (ENEAM) to
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training pattems is n , so that each pattern node can he
regarded as corresponding to a training pattern. Different
from link between input and pattern layer, the nodes of
pattern and category are sparsely connected. Each pattern
node is only connected to the category node that correctly
indicates the its associated class.

analyze several publicly accessible data sets [I I]. EA/EAM
has the properties of fast, stable and finite learning and can
create hyper-ellipsoidal clusters with complex nonlinear
boundaries. Other examples include graph theory-based
methods [IO], singular value decomposition with Bayesian
models [9], partial least squares combined with logic
discrimination and quadratic discriminant analysis [I41 and
support vector machines (SVMs) [16].
In practice, it is common to discriminate more than two
types of cancers. Ramaswamy et al. divided the multi-class
problem as a series of binary classification sub-problems
through either one-versus-all or all-pairs approach [ 18-19].
SVMs, weighted voting and k-nearest-neighbors algorithm
were then used to perform binary classification and the final
label was decided according to some confidence values. Khan
trained perceptrons to categorize small round blue-cell
tumors (SRBCTs) with 4 subclasses [ 121. A nearest shrunken
centroid method was proposed by Tibshirani et al. and was
tested on the SRBCT data set with 100% accuracy [13].
Furthermore, Scherf et al. constructed a gene expression
database to study the relationship between genes and drugs
for 60 human cancer cell lines originating from I O different
tumors, which provides an important criterion for therapy
selection and drug discovery [15].
In our study, we use the probabilistic neural network
(PNN) [21] to address the problem of multiple tuinor
classification without the need to divide it into binary subproblems. As a powerful tool developed to approximate the
Bayesian decision rule, PNN has already shown appealing
performance in a large number of applications [22-241. Here,
we further demonstrate the potential and effectiveness of
PNN in addressing the challenges of gene expression data
analysis with promising results based on several publicly
accessible data sets on cancer researches.
The paper is organized as follows. Section I1 presents a
brief introduction to PNN. Section 111 describes the data sets
and experimental methods. The experimental results are
presented and discussed in section IV and section V
concludes the paper.
11. PROBABILISTIC NEURAL NETWORKS

Probabilistic neural networks were first introduced by
Specht [21] as an implementation of nonparametric Pazen
window estimation with feed-forward neural network
architecture. A typical PNN architecture is illustrated in Fig.
1, which consists of three layers, known as input layer,
pattern layer and category layer [20, 241. The input layer
works as a distribution mechanism and receives input
components from the data set. Therefore, the number of
nodes in this layer is equal to the dimension of the input
vector. All of these nodes are fully connected with the nodes
in the pattern layer, which is considered as the key of PNN.
The PNN requires n pattern nodes if the total number of
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Fig. I . PNN architccturc. Each patlcrii nodc rcprcscnls a partcm in thc
training sct. Thc Baycaian postcrior probability for cach catcgory is obtaincd
as thc output of tho corrcsgonding category nodc.

The PNN calculates the Bayesian posterior probability for
each category. During the training phase, the weights
connecting the input and pattern layer are simply set as the
copy of input vectors, i.e. w i= x , , f o r i = I ,..., n . As
mentioned before, each pattern node merely has connection
with the category node representing the class of the
corresponding pattem. The process is one of the fastest in
known training strategies. However, the cost for the time
efficiency is the storage complexity, one pattem unit is
required for each pattern in the entire training set, which
causes problems when dealing with large volume of data sets.
One of potential solutions is to group training pattems into a
series of clusters and only use the centroid of each cluster to
supervise the network learning [25].
During the test or classification phase, each pattern node
performs a dot product operation with a new pattern vector
x and a weight vector w i, expressed as Pi= X * W , . The
final output of pattern layer is obtained via a nonlinear
transformation.
Usually
a
Gaussian
activation
function, exp((P, - 1) / 0 2 ) ,is used, though other alternatives
are also available [21]. Here, o is the smoothing parameter
of the Gaussian kernel and is also the only one parameter that
is dependent on the users to decide. It has great effect to the
formation of resulting decision boundary and the strategy on
how to select appropriate a was discussed in details by
Specht in [21]. Note that if both the training patterns
(equivalent to weight vectors) and the new pattems are
normalized to unit length, the output of pattern layer can he
represented as
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particular spot and the mean intensity of all filtered genes and
the ultimate expression levels measure is the natural
logarithm of MI.
The data are expressed as a
matrix E = {ei,j}s3x230a,
where e,,j represents the expression

exp((pi - l ) / u 2 )
=exp(-(x'x+wi T w i -2x T w i ) / 2 u 2 ) ,
= exp(-(x - w i ) ~ ( x w i ) / 2c2)

level of gene j in tissue sample i

which is identical to the Parzen window function [21]. In this
sense, each pattern node provides the corresponding category
node with the class conditional probability given the training
pattern. These values are then summed up in the category
layer for each category as the estimated probability for the
new pattern. The label of the pattem can be predicted by just
choosing the maximum probability.
Due to its design, PNN displays many desirable properties
and characteristics in the context of pattem classification.
Among all of those features, the fast training is most
appealing. The training rule is very simple and can be used in
online learning. Only one pass of the training data is required
under the training scheme. Though PNN sacrifices the space
efficiency for it, the cost can be decreased to certain extent
with the introduction of clustering techniques [25].Also, the
structure of PNN makes it very easy to achieve parallel
implementation. Another important feature of PNN is the
fewer user-dependent parameters compared with other
classifiers. There is only one Gaussian kernel width
parameter a relying on the selection of the users. According
to [ZI] and our experiments, it is not difficult to find
appropriate a and the experimental results are not sensitive to
the small changes of a. Moreover, PNN puts the
nonparametric statistical approach into a neural network
framework and provides the output of the neural network
with a new interpretation, i.e. through the form of conditional
probability density function. The resulting probability for
each category makes it possible to investigate the confidence
of assigning a new pattern to a class. Finally, PNN has the
ability to approximate Bayesian optimal decision surfaces
that can be arbitrarily complex.

111. DATA SETS AND EXPERIMENTS

We use two data sets to test PNN performance in multiple
cancer classification.
SRBCT data set. This data set is on the diagnostic
research of small round blue-cell tumors (SRBCTs) of
childhood and consists of 83 samples from four categories,
known as Burkitt lymphomas (BL), the Ewing family of
tumors (EWS), neuroblastoma (NB) and rhabdomyosarcoma
(RMS) [12]. 5 non-SRBCT samples are also included in the
original data set for testing the ability of diagnosis rejection,
hut we do not use them in our study. Gene expression levels
of 6567 genes were measured using cDNA microarray for
each sample, 2308 of which passed the filter that requires the
red intensity of a gene to be greater than 20 and were kept for
further analyses. The relative red intensity (RRI)of a gene is
defined as the ratio between the mean intensity of that

GCM14 data set. This data set is available at http://wwwgenome.wi.mit.eddcgi-bin/cancer/dalasets.cgi.
There are 14
different tumor types, consisting of breast, prostate, lung,
colorectal, lymphoma, bladder, melanoma, uterus, leukemia,
renal, pancreas, ovary, mesothelioma, and CNS cancer, with
218 samples. These samples are divided into three groups in
the original research, 144 for training, 54 for testing, and the
rest 20 as poorly differentiated (PD) tumors. Also, 90 normal
tissue samples are included for the study of discriminating
tumor and normal tissues. In our experiments, we only work
on the 198 tumor samples in the original training and test
sets. Gene expressions for 16,063 genes were measured using
oligonucleotide microarrays. The final matrix is in the form
of E = ~ e i , j l ~ 1 8 x 1 6 ~ 6 3 .
Gene selection. From the above description of the two data
sets used in the paper and other public data sets [3-81, it can
he seen that one of the common feature is the overwhelming
number of measures of gene expression levels compared with
the number of samples. Not all of these genes are relevant to
the discrimination of tumors and sometimes, only a small part
of them is enough for correct classification [3, I l l . The
existence of more genes that do not contribute to the
distinction in the data sets not only increases the
computational complexity, hut impairs the effects of those
relevant ones to some extent. Furthermore, cancer researches
also require identifying the relation of tumors and their
causes in the molecular level, which is imperative in
determining appropriate therapy. Therefore, feature selection
or extraction, also known as informative gene selection, is
critically important in this context.

Principal component analysis (PCA) is a widely used tool
for dimension reduction, which attempts to seek the
projection that best interpret the variation of the data [ZO].
PCA has already been used in some applications on gene
expression data [U]. But according to the experimental
results in [26], PCA cannot always find the correct structure
with just the first few principal components and therefore is
not recommended under general cases. Several other methods
based on ranking genes according to their expression
differentiation under two different classes (represented as + I
and -1 here) have been proposed, examples including:
( I ) Discrimination score [3]:
D(i) = P+ (i) - P - (4
u+(i)+u-(i)
'
where p + ( i ) and p - ( i ) are the mean values of gene i for
the samples in class +I
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and class -1, and u+(i) and

o_(i)are the standard deviations of gene
in class +I and -1.
(2) 1-statistics score [14]:

i

for the samples

where n, and nI are the sizes for samples in the two classes.
(3) TNoM score [IO]:
'
TNoM(i,/)= minErr(d,t j i , / ) ,

IV. RESULTS

d.1

where d is the class label parameter, t represents the
threshold of the gene i , 1, is the label of the kth sample, and

Err(d,f1 i , / ) =

t sign(d(ek,- t ) ) ) is the number of
k

errors of a decision stump rule.
According to some experimental studies, most of these
methods intend to choose the similar subsets of genes and do
not greatly affect the performance of the classifiers. Thus, we
employed the first criterion to select informative genes. The
only change is that we just use the absolute value of the
score. So it reflects the expression level difference between
the two classes for each gene. Gene expresses itself most
differently in two classes will have the highest score. Since
our final goal is to classify multiple types of cancer, we
utilize a one-versus-all strategy to seek gene predictors. In
other words, for a C-class prediction problem, we compare a
particular class with the other C-I classes that are considered
as a whole. We can just select genes according to their
contribution to distinguish each class, or the total score for
each gene is summed over all C comparison and the top
genes are selected with the highest scores. Of course,
painvise strategy can also be used, which performs
comparisons between each pair of classes.

and is regarded as too optimistic [9]. The second strategy
aims to overcome the bias by selecting informative genes at
each step of LOOCV operation. Therefore, genes selected in
the subset may be different for each stage. But generally,
these gene subsets are highly overlapping, with only a small
portion of difference observed. The experimental results are
illustrated and depicted in the next section.

(3

Experiment designs. Since the data sets consist of only a
small number of samples, it is better to use the jackknife
approach, which is also called leave one out cross validation
(LOOCV), to examine the performance of the classifier. For a
data set with n samples, the classifier is trained n times. Each
time, a.different single sample is lefl out as the test point and
the other n-I samples are used to train the classifier.
Performance evaluation of the classifier is estimated by
considering the average accuracy of the n cross-validation
experiments.

We summarize OUI experimental procedure with the
following steps. First, normalize the input pattems to unit
length. Then, two strategies are used. For the first strategy,
we rank and select a set of informative genes with the
adementioned criterion across all samples, and perform the
LOOCV operation with one sample left out for test and the
others for training in the learning and prediction phase. This
method does not consider the effect of bias for gene selection

Fig. 2 describes the classification accuracy for the SRBCT
data set with the selection of different numbers of gene
predictors. We illustrate the results for both the bias included
and free strategy here. From the figure, we can see that there
is just some minor decrease in the performance when bias
free method was used. This shows that the effect of selection
bias may not he very critical in the case of LOOCV
procedure because of the high overlapping of gene subsets.
We also can see the importance of informative genes
selection in tumor classification. The PNN classifier can
achieve 100% accuracy when only top 50 genes are chosen.
If the subset is increased to include all genes in the data set or
to another extreme, reduced to just comprise several genes,
the accuracy will decrease in both cases, though not much.
These suggest that too many or too few genes both deteriorate
the perfomiance of the classifier. Many genes are not related
to the classification and including them in the data set will
bring noise into the classification system. On the other hand,
important information will be wrongly discarded with
inadequate genes chosen. These results are consistent with
those reported in [I21 and [13].
Fig. 3 shows the effects of the smoothing parameter o to
the classification accuracy, when top 100 gene markers are
selected with selection bias free strategy, or all genes are
used. Obviously, it is not difficult to find a kernel width o
that can lead to a satisfying result. With the increase of the
dimensionality, the effective 0 tends to become larger in
order to provide better interpolation.

Fig. 2. The classification accuracy as a function of the number of informarivc
nenes.
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Fig. 3. Thc classification accuracy as a function d o .

The best performance we obtain for the GCM14 data set is
summarized in Table I, in which the numbers along the
diagonal indicate the correct assignment of samples by PNN.
For each one-versus-all comparison, top IO genes are selected
and the corresponding total number of genes is 138. The
accuracy is around 75.3% and can be compared with the
result reported in the original paper that constructs a multiclass prediction scheme consisting of 14 SVMs [18]. From
the table, we also can observe that PNN can correctly classify
most of cases for tumor types like colorectal, lymphoma,
leukemia, mesothelioma and CNS. But for bladder, renal and
ovary cancer, the classifier cannot effectively discriminate
them from other tumor types. The analysis is also supported
by other methods such as SOFMs and SVMs [18].
TABLE I. CONFUSION MATRIX OF P N N FOR 14 TUMOR TYPES:
OVERALL ACCURACY IS 75.3%

Since PNN has the mechanism that can estimate the
confidence of the predictions, it provides us a way to evaluate
the results by comprehensively considering these values.
Table 11 lists the predicted results with the first three largest
confidence values. Almost half of the errors are caused due to
the reason that the confidence value for the correct category
is ranked second or third by the classifier. This suggests that
it is more effective and accurate to make predictions by
combining the information of confidence values.
V. CONCLUSIONS
Cancer classification is critically important for prognosis
and treatment. Microarray technologies provide a new and
effective avenue to address the problem, while bringing many
challenges. Here, we utilized the probabilistic neural network
to distinguish tumor tissues with more than two categories, by
analyzing gene expression profiling. Because of some
limitations in conditions like sample collections, almost all of
the publicly accessible data sets merely include a small set of
samples for each tumor type, in contrast to the rapidly and
persistently increasing capability of gene chip technologies
that also follow the Moore's law [27]. The initial
experimental results demonstrate the potential of PNN,
combined with feature selection technique, in extracting
useful information from these high-dimensional data sets.
More experiments will be performed for further evaluation
with richer data available. In the meantime, new feature
selection approaches are required in order to find informative
genes that are more efficient in prediction and prognosis.
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